Target intelligence / Profile preview

COVID-19 3C-like Protease (3CLpro)

Target
3CLpro
Molecular classification
Enzyme, Protease, Cysteine protease
01

Overview

The COVID-19 3C-like protease (3CLpro), also known as the main protease (Mpro) or nonstructural protein 5 (nsp5), is a cysteine protease essential for SARS-CoV-2 replication. It cleaves viral polyproteins pp1a and pp1ab at eleven conserved sites, releasing nonstructural proteins (nsps) required for forming the replication-transcription complex. Inhibition of 3CLpro blocks viral polyprotein processing, halting virus replication, making it a key target for antiviral drug development.

Other names
Main ProteaseMproNonstructural Protein 5nsp5Chymotrypsin-like Protease
02

Mechanism of action

Inhibition of viral polyprotein processing, halting virus replication.

03

Biological functions

Viral replicationPolyprotein processingProteolysis
04

Disease associations

InfectionCOVID-19
05

Interacting drugs

Covalent inhibitors

2 more in the full profile.

Beyond the preview

Go deeper on COVID-19 3C-like Protease (3CLpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COVID-19 3C-like Protease (3CLpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call